NGD.TO vs. CPRX
Compare and contrast key facts about New Gold Inc. (NGD.TO) and Catalyst Pharmaceuticals, Inc. (CPRX).
Performance
NGD.TO vs. CPRX - Performance Comparison
Loading graphics...
NGD.TO vs. CPRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NGD.TO New Gold Inc. | 1.67% | 233.15% | 86.98% | 44.36% | -29.63% | -32.50% | 143.48% | 9.52% | -74.58% | -12.31% |
CPRX Catalyst Pharmaceuticals, Inc. | 7.52% | 6.71% | 34.82% | -11.61% | 194.32% | 100.86% | -12.44% | 85.71% | -46.73% | 248.67% |
Different Trading Currencies
NGD.TO is traded in CAD, while CPRX is traded in USD. To make them comparable, the CPRX values have been converted to CAD using the latest available exchange rates.
Fundamentals
NGD.TO:
CA$9.63B
CPRX:
$3.15B
NGD.TO:
CA$1.09
CPRX:
$1.68
NGD.TO:
11.16
CPRX:
14.71
NGD.TO:
0.02
CPRX:
0.26
NGD.TO:
6.49
CPRX:
5.35
NGD.TO:
5.04
CPRX:
3.30
NGD.TO:
CA$1.49B
CPRX:
$588.99M
NGD.TO:
CA$767.09M
CPRX:
$726.82M
NGD.TO:
CA$810.05M
CPRX:
$257.78M
Returns By Period
In the year-to-date period, NGD.TO achieves a 1.67% return, which is significantly lower than CPRX's 7.52% return. Over the past 10 years, NGD.TO has underperformed CPRX with an annualized return of 10.00%, while CPRX has yielded a comparatively higher 36.25% annualized return.
NGD.TO
- 1D
- 0.00%
- 1M
- -33.62%
- YTD
- 1.67%
- 6M
- 21.97%
- 1Y
- 128.57%
- 3Y*
- 106.05%
- 5Y*
- 42.91%
- 10Y*
- 10.00%
CPRX
- 1D
- 4.01%
- 1M
- 9.40%
- YTD
- 7.52%
- 6M
- 25.57%
- 1Y
- -1.30%
- 3Y*
- 15.40%
- 5Y*
- 43.51%
- 10Y*
- 36.25%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NGD.TO vs. CPRX — Risk / Return Rank
NGD.TO
CPRX
NGD.TO vs. CPRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for New Gold Inc. (NGD.TO) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NGD.TO | CPRX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.60 | -0.04 | +2.64 |
Sortino ratioReturn per unit of downside risk | 2.81 | 0.19 | +2.63 |
Omega ratioGain probability vs. loss probability | 1.41 | 1.02 | +0.38 |
Calmar ratioReturn relative to maximum drawdown | 4.56 | -0.10 | +4.66 |
Martin ratioReturn relative to average drawdown | 17.34 | -0.18 | +17.51 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| NGD.TO | CPRX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.60 | -0.04 | +2.64 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.71 | 0.93 | -0.22 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.16 | 0.59 | -0.43 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.01 | 0.17 | -0.16 |
Correlation
The correlation between NGD.TO and CPRX is 0.03, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
NGD.TO vs. CPRX - Dividend Comparison
Neither NGD.TO nor CPRX has paid dividends to shareholders.
Drawdowns
NGD.TO vs. CPRX - Drawdown Comparison
The maximum NGD.TO drawdown since its inception was -98.39%, which is greater than CPRX's maximum drawdown of -90.42%. Use the drawdown chart below to compare losses from any high point for NGD.TO and CPRX.
Loading graphics...
Drawdown Indicators
| NGD.TO | CPRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.39% | -94.25% | -4.14% |
Max Drawdown (1Y)Largest decline over 1 year | -35.75% | -27.29% | -8.46% |
Max Drawdown (5Y)Largest decline over 5 years | -69.29% | -45.37% | -23.92% |
Max Drawdown (10Y)Largest decline over 10 years | -91.12% | -64.87% | -26.25% |
Current DrawdownCurrent decline from peak | -71.56% | -5.89% | -65.67% |
Average DrawdownAverage peak-to-trough decline | -80.86% | -52.51% | -28.35% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.41% | 15.10% | -5.69% |
Volatility
NGD.TO vs. CPRX - Volatility Comparison
New Gold Inc. (NGD.TO) has a higher volatility of 20.35% compared to Catalyst Pharmaceuticals, Inc. (CPRX) at 10.16%. This indicates that NGD.TO's price experiences larger fluctuations and is considered to be riskier than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| NGD.TO | CPRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.35% | 10.16% | +10.19% |
Volatility (6M)Calculated over the trailing 6-month period | 50.26% | 23.52% | +26.74% |
Volatility (1Y)Calculated over the trailing 1-year period | 62.83% | 34.65% | +28.18% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 60.65% | 46.88% | +13.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 63.57% | 61.94% | +1.63% |
Financials
NGD.TO vs. CPRX - Financials Comparison
This section allows you to compare key financial metrics between New Gold Inc. and Catalyst Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities